Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

New drug shows impressive results against lipoprotein(a), a genetic form of cholesterol that affects millions but remains ...

About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t treat.

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...

Looking for ways to manage high cholesterol? A leading cardiologist and top dietitian say fried foods and meat aren't the ...

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...

Visit-to-visit variability in lipid levels is associated with an increased risk for heart failure in patients with T2D, ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have multiple drugs to treat it ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...

Many Americans are unaware that elevated levels of this particle — known as lipoprotein(a) or Lp(a) — are circulating in their blood. Elevated Lp(a) cannot be modified with lifestyle changes ...